Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Advances in Experimental Medicine and Biology|November 13, 2007
Estrogen receptors in resistance to hormone therapyMatthew H Herynk, Suzanne A W Fuqua
Endocrine Reviews|December 8, 2004
Estrogen receptor mutations in human diseaseMatthew H Herynk, Suzanne A W Fuqua
Clinical & Experimental Metastasis|July 15, 2003
Activation of c-Met in colorectal carcinoma cells leads to constitutive association of tyrosine-phosphorylated beta-cateninMatthew H Herynk, Rachael Tsan, Robert Radinsky, et al.
Journal of Experimental Therapeutics & Oncology|June 8, 2007
Activation of Src by c-Met overexpression mediates metastatic properties of colorectal carcinoma cellsMatthew H Herynk, Jing Zhang, Nila U Parikh, et al.
Oncogene|March 1, 2005
The guanine nucleotide exchange factor Tiam1 increases colon carcinoma growth at metastatic sites in an orthotopic nude mouse modelMeghan E Minard, Matthew H Herynk, John G Collard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Reduced c-Met expression by an adenovirus expressing a c-Met ribozyme inhibits tumorigenic growth and lymph node metastases of PC3-LN4 prostate tumor cells in an orthotopic nude mouse modelSun Jin Kim, Marjorie Johnson, Kristen Koterba, et al.
The Journal of Nursing Administration|April 25, 2014
The Affordable Health Care Act annual wellness visits: the effectiveness of a nurse-run clinic in promoting adherence to mammogram and colonoscopy recommendationsTheresa M Tetuan, Ruth Ohm, Matthew H Herynk, et al.
Breast Cancer Research and Treatment|October 21, 2009
A hypersensitive estrogen receptor alpha mutation that alters dynamic protein interactionsMatthew H Herynk, Torsten Hopp, Yukun Cui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 5, 2007
Association between the estrogen receptor alpha A908G mutation and outcomes in invasive breast cancerMatthew H Herynk, Irma Parra, Yukun Cui, et al.
Molecular Cancer Therapeutics|December 19, 2006
Cooperative action of tamoxifen and c-Src inhibition in preventing the growth of estrogen receptor-positive human breast cancer cellsMatthew H Herynk, Amanda R Beyer, Yukun Cui, et al.
Pageof 2